MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans

European Journal of Immunology

Volumn 35, Issue 3, 2005, Pages 870-878

  Biondo, Carmelo ^a   Midiri, Angelina ^a   Messina, Luciano ^a   Tomasello, Francesco ^a   Garufi, Gabriella ^a   Catania, Maria Rosaria ^b   Bombaci, Mauro ^a   Beninati, Concetta ^a   Teti, Giuseppe ^a,c   Mancuso, Giuseppe ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Cryptococcus neoformans; IFN ; Innate immunity; MyD88; Toll like receptors

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12P40; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE RELEASE; GENE MUTATION; HOST RESISTANCE; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION RESISTANCE; INFECTION SENSITIVITY; INNATE IMMUNITY; MOUSE; MOUSE MUTANT; MOUSE STRAIN; MYCOSIS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE; SURVIVAL; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, DIFFERENTIATION; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; INTERFERON TYPE II; INTERLEUKIN-12; MACROPHAGES, PERITONEAL; MICE; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 20144382352     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425799     Document Type: Article

References (34)

1. Powderly, W. G., Cryptococcal meningitis and AIDS. Clin. Infect. Dis. 1993. 17: 837-842.
2. Ruiz, A. and Bulmer, G. S., Particle size of airborne Cryptococcus neoformans in a tower. Appl. Environ. Microbiol. 1981. 41: 1225-1229.
3. He, W., Casadevall, A., Lee, S. C. and Goldman, D. L., Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis. Infect. Immun. 2003. 71: 930-936.
4. Cross, C. E. and Bancroft, G. J., Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect. Immun. 1995. 63: 2604-2611.
5. Goldman, D. L., Lee, S. C., Mednick, A. J., Montella, L. and Casadevall, A., Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide. Infect. Immun. 2000. 68: 832-838.
6. Herring, A. C., Lee, J., McDonald, R. A., Toews, G. B. and Huffnagle, G. B., Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect. Immun. 2002. 70: 2959-2964.
7. Kawakami, K., Hossain, Q. M., Zhang, T., Koguchi, Y., Xie, Q., Kurimoto, M. and Saito, A., Interleukin 4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon gamma inducing cytokines. Cell Immunol. 1999. 197:55-61.
8. Hage, C. A., Wood, K. L., Winer-Muram, H. T., Wilson, S. J., Sarosi, G. and Knox, K. S., Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy. Chest 2003. 124: 2395-2397.
9. Takeda, K. and Akira, S., Microbial recognition by Toll-like receptors. J. Dermatol. Sci. 2004. 34: 73-82
10. Romani, L., Immunity to fungal infections. Nat. Rev. Immunol. 2004. 4:1-23.
11. Bellocchio, S., Montagnoli, C., Bozza, S., Gaziano, R., Rossi, G., Mambula, S. S., Vecchi, A., Mantovani, A., Levitz, S. M. and Romani, L., The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol. 2004. 172: 3059-3069.
12. Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K. and Akira, S., Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999. 11: 443-451.
13. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K. and Akira, S., Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J. Immunol. 1999. 162: 3749-3752.
14. Villamon, E., Gozalbo, D., Roig, P., O'Connor, J. E., Fradelizi, D. and Gil, M. L., Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect. 2004. 6: 1-7.
15. Jouault, T., Ibata-Ombetta, S., Takeuchi, O., Trinel, P. A., Sacchetti, P., Lefebvre, P., Akira, S. and Poulain, D., Candida albicans phospholipomannan is sensed through toll-like receptors. J. Infect. Dis. 2003. 188: 165-172.
16. Netea, M. G., Warris, A., Van der Meer, J. W., Fenton, M. J., Verver-Janssen, T. J., Jacobs, L. E., Andresen, T., Verweij, P. E and Kullberg, B. J. Aspergillus fumigatus evades immune recognition during germination through loss of Toll-like receptor-4-mediated signal transduction. J. Infect. Dis. 2003. 188: 320-326.
17. Shoham, S., Huang, C., Chen, J. M., Golenbock D. T. and Levitz, S. M., Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J. Immunol. 2001. 166: 4620-4626.
18. Yauch, L. E., Mansour, M. K., Shoham, S., Rottman, J. B. and Levitz, S. M., Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect. Immun. 2004. 72: 5373-5382.
19. Mancuso, G., Midiri, A., Beninati, C., Biondo, C., Galbo, R., Akira, S., Henneke, P., Golenbock, D. and Teti, G., Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease. J. Immunol. 2004. 172: 6324-6329.
20. Ellingsen, E., Morath, S., Flo, T., Schromm, A., Hartung, T., Thiemermann, C., Espevik, T., Golenbock, D., Foster, D., Solberg, R., Aasen, A. and Wang, J., Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med. Sci. Monit. 2002. 8: BR149-156.
21. Kawakami, K., Koguchi, Y., Qureshi, M. H., Miyazato, A., Yara, S., Kinjo, Y., Iwakura, Y., Takeda, K., Akira, S., Kurimoto, M. and Saito, A., IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. J. Immunol. 2000. 165: 941-947.
22. Marr, K. A., Balajee, S. A., Hawn, T. R., Ozinsky, A., Pham, U., Akira, S., Aderem, A. and Liles, W. C., Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect. Immun. 2003. 71: 5280-5286
23. Aguirre, K., Havell, E. A., Gibson, G. W. and Johnson, L. L., Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun. 1995. 63: 1725-1731.
24. Biondo, C., Beninati, C., Bombaci, M., Messina, L., Mancuso, G., Midiri, A., Galbo, R. and Teti, G., Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans. Infect. Immun. 2003. 71: 5412-5417.
25. Kawakami, K., Tohyama, M., Qifeng, X. and Saito, A., Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect. Immun. 1997. 65: 1307-1312.
26. Netea, M. G., Van Der Graaf, C. A., Vonk, A. G., Verschueren, I., Van Der Meer, J. W. and Kullberg, B. J., The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis. 2002. 185: 483-1489.
27. Netea, M. G., Sutmuller, R., Hermann, C., Van der Graaf, C. A., Van der Meer, J. W., van Krieken, J. H., Hartung, T. G., Adema, G. and Kullberg, B. J., Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 2004. 172: 3712-3718.
28. Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K. and Akira, S., Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998. 9: 143-150.
29. Jacobson, E. S. and Ayers, D. J., Auxotrophic mutants of Cryptococcus neoformans. J. Bacteriol. 1979. 139: 318-319.
30. Biondo, C., Beninati, C., Delfino, D., Oggioni, M., Mancuso, G., Midiri, A., Bombaci, M., Tomaselli, G. and Teti, G., Identification and cloning of a cryptococcal deacetylase that produces protective immune responses. Infect. Immun. 2002. 70: 2383-2391.
31. Delfino, D., Cianci, L., Migliardo, M., Mancuso, G., Cusumano, V., Corradini, C. and Teti, G., Tumor necrosis factor-inducing activities of Cryptococcus neoformans components. Infect Immun. 1996. 64: 5199-5204.
32. Mancuso, G., Midiri, A., Beninati, C., Piraino, G., Valenti, A., Nicocia, G., Teti, D., Cook, J. and Teti, G., Mitogen-activated protein kinases and NF-kappa B are involved in TNF-alpha responses to group B streptococci. J Immunol. 2002. 169:1401-1409.
33. Morath, S., Geyer, A. and Hartung, T., Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 2001. 193: 393-397.
34. Giulietti, A., Overbergh, L., Valckx, D., Decallonne, B., Bouillon, R. and Mathieu, C., An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001. 25: 386-401.